Seroma Clinical Trial - fixAtion of skiN Flaps After Mastectomy Using

Status Not yet recruiting

Clinical Trial Summary

Rationale: Flap fixation significantly reduces the incidence of seroma formation after mastectomy. Therefore, research should focus on finding the most optimal way to secure the skin flaps to the pectoral muscle. Previous studies have compared running sutures, interrupted sutures and tissue glue application to conventional wound closure. A recent systematic review with network meta-analysis indicated running sutures as the most optimal technique, however direct comparisons and high quality articles were lacking. Objective: This prospective trial aims to directly compare running sutures with interrupted sutures in order to prevent complications in patients undergoing a mastectomy. Study design: This trial will combine a retrospective cohort from the previous SARA-trial in Zuyderland MC with a randomised prospective trial. This study design was chosen to acquire a sample size with sufficient power and the ability to conduct this study in an acceptable time frame. Study population: A retrospective cohort of patients participating in the SARA trial (RCT) and a prospective cohort of patients undergoing a mastectomy for breast cancer. Intervention: Group 1: Flap fixation after mastectomy with running sutures. Group 2: Flap fixation after mastectomy with interrupted sutures. Main study parameters/endpoints: The primary endpoint is the incidence of complications requiring interventions in both groups, including clinically significant seroma, infections and bleeding complications. Secondarily, the length of the procedure and cosmetic results will be compared. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: When participating, patients will undergo 3 additional outpatient clinic visits. Study visits will be combined with regular visits where possible, including the first postoperative visit after 7-10 days and either the 6 week or 3 month visit.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Seroma

Clinical Trial Details

NCT number	NCT05941351
Study type	Interventional
Source	Zuyderland Medisch Centrum
Contact	Merel Spiekerman van Weezelenburg, MD
Phone	+31884597777
Email	m.spiekermanvanweezelenburg@zuyderland.nl
Status	Not yet recruiting
Phase	N/A
Start date	January 1, 2025
Completion date	March 1, 2027

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04496180` - Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy	N/A
Completed	`NCT03665883` - Use of Diathermy Versus Blunt Dissection in TEP for Inguinal Hernia	N/A
Completed	`NCT03650868` - The Effect of Thoracal Paravertebral Block on Seroma Reduction in Breast Surgery	N/A
Completed	`NCT02668588` - Extended-release of Octreotide (LF-PB) for the Treatment of Seroma	Phase 2
Completed	`NCT01454713` - Retrospective Analysis of Veritas in Breast Reconstruction	N/A
Not yet recruiting	`NCT04471142` - Effectiveness of Compressive Bandage Use in Seroma Prevention	N/A
Not yet recruiting	`NCT02967627` - VAC Dressings for Colorectal Resections	N/A
Recruiting	`NCT03598712` - Local Compression Seroma DIminution Objective (CLODIS)	Phase 3
Completed	`NCT04666051` - Fibrin Glue in Inguinal Lymphadenectomy	N/A
Recruiting	`NCT01454167` - Acid Base and Electrolytes Patterns in Drains Operational Wounds and Its Relation to Complications	N/A
Completed	`NCT01112735` - Efficacy and Safety of ARTISS for Flap Adherence in Abdominoplasty	Phase 2
Completed	`NCT00968318` - Excision of Strip of Deep Fascia to Reduce Seroma Formation and Extrusion of Tissue Expanders	N/A
Completed	`NCT03647930` - The Effect of Arista on Post-Operative Bleeding and Wound Drainage Following Mastectomy	N/A
Recruiting	`NCT05509829` - EvaLuating negAtive pressUre Wound theRapy in brEast coNserving Surgery	N/A
Terminated	`NCT04818580` - Progressive Tension Sutures in Gender Affirming Mastectomy	N/A
Withdrawn	`NCT02568085` - Trial Evaluating Use of Arista in Total Thyroidectomy	N/A
Active, not recruiting	`NCT01942707` - Scarpa´s Fascia in the Formation of Seroma Post Abdominoplasty After Bariatric Surgery	N/A
Recruiting	`NCT03167944` - Traditional Electrosurgery System Versus Low Thermal Tissue Dissection System for Total Mastectomy	N/A
Recruiting	`NCT03190876` - Seroma Prevention After Body Contouring Procedures	N/A
Completed	`NCT03590704` - Safety of the Use of Compressive Taping in Seroma	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

fixAtion of skiN Flaps After Mastectomy Using ruNning or Interrupted suturEs for Combatting Seroma — ANNIE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms